In order to prevent spam,
this email address cannot be copied.
Schizophrenia Research Forum: Researcher Profile - Gavin Reynolds
Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Researcher Profile - Gavin Reynolds

RESEARCHER INFORMATION
First Name:Gavin
Last Name:Reynolds
Title:Professor
Advanced Degrees:PhD
Affiliation:Sheffield Hallam University (Honorary Prof)
Street Address 1:16 Moorside
City:Sheffield
State/Province:S Yorks
Zip/Postal Code:S10 4LN
Country/Territory:United Kingdom
Phone:+447740651500
Fax:+44 7740651500
Email Address: gavin.reynolds@hotmail.com
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 6 May 2012]
View all comments by Gavin Reynolds
Clinical Interests:
Schizophrenia, Bipolar disorder
Research Focus:
Neurotransmission, GABAergic transmission, Pharamacology, Neuroanatomy/Systems Neuroscience, Pharmacology, Animal models, Neuropathology, Genetics, Glutamatergic transmission
Work Sector(s):
University
Top Papers
Reynolds GP (1983) Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305, 527-529.
Reynolds GP, Czudek C, Andrews HB (1990) Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol Psychiatry 27:1038-1044.
Beasley CL, Reynolds GP (1997) Parvalbumin-immunoreactive neurons are reduced in the frontal cortex of schizophrenics. Schiz Res 24, 349-355.
Zhang ZJ, Reynolds GP (2002) A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schiz Res 55, 1-10.
Reynolds GP, Zhang ZJ, Zhang XB (2002) Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 359, 2086-2087.
Zhang ZJ, Yao ZJ, Liu, W, Fang Q, Reynolds GP (2004) Effects of antipsychotics on fat deposition and changes in leptin and insulin levels: Magnetic resonance imaging study of previously untreated people with schizophrenia. Brit J Psychiat 184, 58-62.
Templeman LA, Reynolds GP, Arranz B, San L (2005) Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenetics 15, 195-200.
Reynolds GP, Arranz B, Templeman LA, Fertuzinhos S, San L (2006) Effect of a 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naïve psychotic patients. Am J Psychiat 163, 1826-1829.
Yevtushenko O, Cooper SJ, O’Neill R, Doherty JK, Woodside JV, Reynolds GP (2008) The influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia. Brit J Psychiat 192, 424-428.
Kirk SL, Glazebrook J, Grayson B, Neill JC, Reynolds GP (2009) Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors. Psychopharmacology 207, 119-125.



Research Participants
Collaborators
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright